Trends and persistent disparities in incidence, mortality, and survival of pancreatic cancer: A Surveillance, Epidemiology, and End Results program–based retrospective cohort study (2000–2021). This ...

This research article is published in the Case Reports in Clinical Radiology, published by Scientific Scholar.Neuroendocrine tumours (NETs) affecting the extrahepatic bile ducts are ...

NET as a potentially important new option for NET patients. Perspective Therapeutics, Inc. (NYSE:CATX) will discuss these ...

EUS at the age of 48 revealed a 5-mm solid lesion in the tail of the pancreas. FNA biopsy showed a grade 2 neuroendocrine tumor. After distal pancreatectomy, the surgical specimen showed a T1 grade 2 ...

Several AON physicians and leaders shared new cancer research at one of oncology’s most influential gatheringsFORT MYERS, Fla ...

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs") today announced the presentation of groundbreaking clinical data from a multicenter phase Ib/II clinical trial evaluating LBL-024, an anti-PD-L1/4-1BB ...

The FDA has approved new agents in ovarian cancer and non–small cell lung cancer and paved the way for novel antibody-drug conjugate developments.

In a somber end to an FDA advisory committee’s two-day scouring of multiple drugmakers’ oncology data, Pfizer’s pitch to ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...